Activation of Monocyte/macrophage Functions Related to Acute Atheroma Complication by Ligation of CD40: Induction of Collagenase, Stromelysin, and Tissue Factor
Overview
Authors
Affiliations
Background: Plaque disruption with thrombosis commonly causes the acute coronary syndromes. Macrophages, abundant at sites of plaque rupture, release proteinases that weaken plaques and express tissue factor (TF), which initiates thrombosis. The signals that induce expression of these macrophage functions, particularly TF, remain obscure. Recent studies have localized the receptor CD40 and its ligand in human atheroma. This study tested the hypothesis that ligation of CD40 can activate key mononuclear phagocyte functions related to clinical manifestations of atheroma.
Methods And Results: Stimulation of human monocytes/macrophages through CD40 by either membranes from activated T cells or recombinant CD40L (rCD40L) induced expression of interstitial collagenase, stromelysin, and TF protein and activity. In contrast, the soluble cytokines interleukin-1 or tumor necrosis factor-alpha did not induce or weakly induced TF expression. Neutralization with anti-CD40L antibody markedly inhibited these actions of both T-cell membranes and rCD40L.
Conclusions: By inducing the expression of matrix-degrading proteinases and of TF procoagulant, CD40 signaling may contribute to the triggering of acute coronary events.
The Multitarget Action of Vitamins in the Ischemic Stroke.
Scotti L, da Silva P, Monteiro A, Santos Aquino de Araujo R, do Nascimento V, Monteiro K Curr Top Med Chem. 2024; 24(28):2465-2488.
PMID: 39301898 DOI: 10.2174/0115680266316939240909070627.
Advances in Nano-Functional Materials in Targeted Thrombolytic Drug Delivery.
Ren T, Mi Y, Wei J, Han X, Zhang X, Zhu Q Molecules. 2024; 29(10).
PMID: 38792186 PMC: 11123875. DOI: 10.3390/molecules29102325.
Yang L, Yang J, Zhang X, Ye X, Liu Y, Wei B BMC Anesthesiol. 2024; 24(1):32.
PMID: 38243164 PMC: 10797713. DOI: 10.1186/s12871-023-02381-w.
Platelet-monocyte aggregates: molecular mediators of thromboinflammation.
Rolling C, Barrett T, Berger J Front Cardiovasc Med. 2023; 10:960398.
PMID: 37255704 PMC: 10225702. DOI: 10.3389/fcvm.2023.960398.
New Insights into Pathophysiology and New Risk Factors for ACS.
Nardin M, Verdoia M, Laera N, Cao D, De Luca G J Clin Med. 2023; 12(8).
PMID: 37109221 PMC: 10146393. DOI: 10.3390/jcm12082883.